The report demonstrates "that significant progress can be made in malaria control given sustained financing and improved distribution of control interventions such as ACTs [artemisinin-based combination therapies], bed nets and indoor residual spraying," Chris Hentschel, president and chief executive officer of Switzerland-based nonprofit Medicines for Malaria Venture, writes in an email.
"It is heartening to see that use of ACTs in children with fever has increased somewhat to 15%, but we need to radically improve these numbers. There remains however a huge gap in financing and coverage if we are to move closer to malaria elimination in the main endemic areas of Sub Saharan Africa," Hentschel adds.
Others expressed concern that the report may leave an impression that malaria is under control. Richard Tren, director of Africa Fighting Malaria, a nonprofit health advocacy group based in South Africa and the United States, says that success in a few areas is not an accurate indicator of overall progress. Reached by email while traveling in the United Kingdom, Tren writes: "Overall the report does show an encouraging trend of declining malaria cases and deaths. This is good news and to be expected given the substantial increase in funding for malaria control. We do have a concern however that WHO and other stakeholders are playing up the successes when in reality the data are based on a few countries."
The report does, however, highlight ongoing areas of concern, including the lopsided distribution of funding. The vast majority of the money earmarked for malaria control is spent in smaller countries with lower disease burdens, it states. "More attention needs to be given to ensuring success in large countries that account for most malaria cases and deaths, and protecting the gains that have been made."
Another threat to controlling malaria, according to the report, is mosquito resistance to insecticides. Tren says the WHO offers no plan of action to address this problem and, in general, has a "blind spot" when it comes to insecticides. "This is a real problem -to control insect borne diseases, we need insecticides," writes Tren. "The WHO has shown a remarkable lack of leadership on insecticides -routinely siding with environmental activists from the West against the interests of the poor and vulnerable living in poor countries."
While noting the major increase in donor funding for malaria control, Tren expresses concern that many countries struggling with malaria are not investing enough domestically to fight the disease and says that lasting success cannot be achieved with external dollars alone. Countries with rapidly growing economies, such as India and China, are receiving millions of dollars for malaria interventions that should go to countries that genuinely lack budgets for disease control, he says.
"This is a long tough road and we are by no means beating malaria -progress is being made, but this disease can come back if success is claimed too soon," Tren writes. "There are an awful lot of policy problems that need to be dealt with -developing new insecticides one of the most important -and it seems like WHO and its partners are reluctant to do so." -Roger Collier, CMAJ DOI:10.1503/cmaj.109-3139 
